CMS renews payment coverage for Viz.ai’s stroke CT platform

The Centers for Medicare & Medicaid Services has renewed New Technology Add-on Payments for Viz.ai’s artificial intelligence stroke software, the firm announced Wednesday.

The San Francisco-based AI vendor first gained federal clearance for its Viz LVO algorithm back in 2018. And last September, Medicare approved reimbursement for the tool—formerly known as Viz ContaCT—making it the first stroke CT algorithm to land NTAP coverage.

The platform utilizes AI to help radiologists automatically identify suspected large vessel occlusion strokes more quickly before they grow worse.

Viz.ai said CMS evaluated other AI companies, but only renewed reimbursement for Viz LVO due to “strong clinical outcomes." CMS has agreed on payments of up to $1,040 per eligible patient.

“I am proud to learn that Viz LVO was able to maintain this reimbursement, especially given the stringent guidelines that other AI companies were unable to meet,” Chief Clinical Officer of the company Jayme Strauss, said Aug. 4. “The purpose of the Viz LVO NTAP is to give more patients access to the highest standard of care, which is directly in line with the mission of the company.”

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.